VAERS Explorer
Back to explore

Report #2832747

Received Mar 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
17 yrs
State
NH
Recovered
Unknown
Vaccinated
Mar 18, 2025
Onset
Mar 18, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKX005044—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No additional AE reported; dose of GARDASIl-9 expired on 1/2/2025 and was administered on 3/18/2025 to a 17-year-old female consumer; This spontaneous report was received from a physician assistant and refers to a 17-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-Mar-2025, the patient was vaccinated with an expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (dose, route, anatomical site, lot #X005044, expiration date: 02-Jan-2025) for prophylaxis (expired product administered). No additional adverse event was reported (no adverse event). Additional information is not expected.